Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03341559 · ClinicalTrials.gov registry record
Spatial Frequency Domain Imaging (SFD) for Assessment of Diabetic Foot Ulcer Development and Healing
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 23
- Enrollment target
NCT03341559: Completed study, sponsored by University of Southern California.
NCT03341559 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03341559 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
This study is designed to evaluate the ability of Spatial Frequency Domain Imaging (SFDI) to measure perfusion in lower extremities for prediction of both healing and formation of diabetic foot ulcers. The investigators will perform longitudinal imaging (for 12 months) in two cohorts of subjects
Primary Outcome
SFDI data outputs
Interventions
- DEVICE Spatial Frequency Domain Imaging (SFDI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2020-02-13 |
What the finished NCT03341559 record still lists
NCT03341559 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Spatial Frequency Domain Imaging (SFDI) is the first listed.
NCT03341559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03341559 about?
NCT03341559 is a clinical study titled "Spatial Frequency Domain Imaging (SFD) for Assessment of Diabetic Foot Ulcer Development and Healing". This study is designed to evaluate the ability of Spatial Frequency Domain Imaging (SFDI) to measure perfusion in lower extremities for prediction of both healing and formation of diabetic foot ulcers. The investigators will perform longitudinal imaging (for 12 months) in two cohorts of subjects
What is the current status of trial NCT03341559?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2018-03-20. Estimated completion is 2020-02-13.
What interventions are being tested in trial NCT03341559?
The interventions under investigation include: Spatial Frequency Domain Imaging (SFDI) (DEVICE).
Who is sponsoring clinical trial NCT03341559?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI